Urothelial Carcinoma Treatment Market Insights and Forecast Analysis 2027–2036
The global urothelial carcinoma treatment market was valued at USD 4.2 billion in 2026 and is projected to cross USD 29.69 billion by the end of 2036, expanding at more than 21.6% CAGR during the forecast period. The market is being reshaped by advances in immuno-oncology, targeted therapies, antibody-drug conjugates, improved molecular diagnostics, and the increasing use of combination treatment strategies.
